A Case for Rimantadine to Be Marketed in Canada for Prophylaxis of Influenza a Virus Infection
PURPOSE: To evaluate the efficacy and safety of amantadine and rimantadine, the first generation antivirals, for the prophylaxis of influenza virus.
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2003-01-01
|
| Series: | Canadian Respiratory Journal |
| Online Access: | http://dx.doi.org/10.1155/2003/453183 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832559921275600896 |
|---|---|
| author | Fawziah Marra Carlo A Marra H Grant Stiver |
| author_facet | Fawziah Marra Carlo A Marra H Grant Stiver |
| author_sort | Fawziah Marra |
| collection | DOAJ |
| description | PURPOSE: To evaluate the efficacy and safety of amantadine and rimantadine, the first generation antivirals, for the prophylaxis of influenza virus. |
| format | Article |
| id | doaj-art-9f09c2b865bc4c248fc3c9c34fb6d0e8 |
| institution | Kabale University |
| issn | 1198-2241 |
| language | English |
| publishDate | 2003-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Respiratory Journal |
| spelling | doaj-art-9f09c2b865bc4c248fc3c9c34fb6d0e82025-02-03T01:28:52ZengWileyCanadian Respiratory Journal1198-22412003-01-0110738138810.1155/2003/453183A Case for Rimantadine to Be Marketed in Canada for Prophylaxis of Influenza a Virus InfectionFawziah Marra0Carlo A Marra1H Grant Stiver2Faculty of Pharmaceutical Sciences, University of British Columbia, and British Columbia Centre for Disease Control, CanadaFaculty of Pharmaceutical Sciences, University of British Columbia, and Centre for Health Evaluation and Outcomes Sciences, St Paul’s Hospital, Department of Health Care and Epidemiology, Faculty of Medicine, CanadaFaculty of Medicine, University of British Columbia, and Division of Infectious Diseases, Department of Medicine, Vancouver Hospital and Health Sciences Centre, Vancouver, British Columbia, CanadaPURPOSE: To evaluate the efficacy and safety of amantadine and rimantadine, the first generation antivirals, for the prophylaxis of influenza virus.http://dx.doi.org/10.1155/2003/453183 |
| spellingShingle | Fawziah Marra Carlo A Marra H Grant Stiver A Case for Rimantadine to Be Marketed in Canada for Prophylaxis of Influenza a Virus Infection Canadian Respiratory Journal |
| title | A Case for Rimantadine to Be Marketed in Canada for Prophylaxis of Influenza a Virus Infection |
| title_full | A Case for Rimantadine to Be Marketed in Canada for Prophylaxis of Influenza a Virus Infection |
| title_fullStr | A Case for Rimantadine to Be Marketed in Canada for Prophylaxis of Influenza a Virus Infection |
| title_full_unstemmed | A Case for Rimantadine to Be Marketed in Canada for Prophylaxis of Influenza a Virus Infection |
| title_short | A Case for Rimantadine to Be Marketed in Canada for Prophylaxis of Influenza a Virus Infection |
| title_sort | case for rimantadine to be marketed in canada for prophylaxis of influenza a virus infection |
| url | http://dx.doi.org/10.1155/2003/453183 |
| work_keys_str_mv | AT fawziahmarra acaseforrimantadinetobemarketedincanadaforprophylaxisofinfluenzaavirusinfection AT carloamarra acaseforrimantadinetobemarketedincanadaforprophylaxisofinfluenzaavirusinfection AT hgrantstiver acaseforrimantadinetobemarketedincanadaforprophylaxisofinfluenzaavirusinfection AT fawziahmarra caseforrimantadinetobemarketedincanadaforprophylaxisofinfluenzaavirusinfection AT carloamarra caseforrimantadinetobemarketedincanadaforprophylaxisofinfluenzaavirusinfection AT hgrantstiver caseforrimantadinetobemarketedincanadaforprophylaxisofinfluenzaavirusinfection |